Literature DB >> 19025481

Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast.

Brian Wells Pence1, Nathan M Thielman, Kathryn Whetten, Jan Ostermann, Virender Kumar, Michael J Mugavero.   

Abstract

Alcohol and drug use are common among HIV-infected patients and are important determinants of secondary transmission risk and medication adherence. As part of the Coping with HIV/AIDS in the Southeast (CHASE) Study, 611 HIV-infected patients were consecutively recruited from eight clinical care sites in five southeastern U.S. states in 2001-2002. We examined the distribution and predictors of alcohol and drug use in this sample with an emphasis on psychosocial predictors of use. In the prior 9 months, 27% of participants drank alcohol and 7% drank to intoxication at least weekly. The most common drugs used at least weekly were marijuana (12%) and crack (5%); 11% used a non-marijuana drug. 7% reported polysubstance use (use of multiple substances at one time) at least weekly. Injection drug use was rare (2% injected at least once in the past 9 months). There were few differences in alcohol and drug use across sociodemographic characteristics. Stronger adaptive coping strategies were the most consistent predictor of less frequent alcohol and drug use, in particular coping through action and coping through relying on religion. Stronger maladaptive coping strategies predicted greater frequency of drinking to intoxication but not other measures of alcohol and drug use. Those with more lifetime traumatic experiences also reported higher substance use. Interventions that teach adaptive coping strategies may be effective in reducing alcohol and substance use among HIV-positive persons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19025481      PMCID: PMC2929148          DOI: 10.1089/apc.2008.0022

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  46 in total

1.  Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: western United States versus other regions. Supplement to HIV/AIDS Surveillance Study Group.

Authors:  P S Sullivan; A K Nakashima; D W Purcell; J W Ward
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-11-01

2.  A randomized controlled trial of a coping group intervention for adults with HIV who are AIDS bereaved: longitudinal effects on grief.

Authors:  Kathleen J Sikkema; Nathan B Hansen; Musie Ghebremichael; Arlene Kochman; Nalini Tarakeshwar; Christina S Meade; Heping Zhang
Journal:  Health Psychol       Date:  2006-09       Impact factor: 4.267

3.  The stress process.

Authors:  L I Pearlin; M A Lieberman; E G Menaghan; J T Mullan
Journal:  J Health Soc Behav       Date:  1981-12

4.  Progression to AIDS: the effects of stress, depressive symptoms, and social support.

Authors:  J Leserman; E D Jackson; J M Petitto; R N Golden; S G Silva; D O Perkins; J Cai; J D Folds; D L Evans
Journal:  Psychosom Med       Date:  1999 May-Jun       Impact factor: 4.312

5.  Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).

Authors:  Patrick Peretti-Watel; Bruno Spire; France Lert; Yolande Obadia
Journal:  Drug Alcohol Depend       Date:  2006-04       Impact factor: 4.492

6.  Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure.

Authors:  J Leserman; Z Li; D A Drossman; T C Toomey; G Nachman; L Glogau
Journal:  Psychosom Med       Date:  1997 Mar-Apr       Impact factor: 4.312

7.  Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study.

Authors:  Shanta R Dube; Vincent J Felitti; Maxia Dong; Daniel P Chapman; Wayne H Giles; Robert F Anda
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

8.  Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study.

Authors:  J Leserman; J M Petitto; D O Perkins; J D Folds; R N Golden; D L Evans
Journal:  Arch Gen Psychiatry       Date:  1997-03

9.  Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States.

Authors:  Medha Vyavaharkar; Linda Moneyham; Abbas Tavakoli; Kenneth D Phillips; Carolyn Murdaugh; Kirby Jackson; Gene Meding
Journal:  AIDS Patient Care STDS       Date:  2007-09       Impact factor: 5.078

10.  Relation of lifetime trauma and depressive symptoms to mortality in HIV.

Authors:  Jane Leserman; Brian Wells Pence; Kathryn Whetten; Michael J Mugavero; Nathan M Thielman; Marvin S Swartz; Dalene Stangl
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

View more
  51 in total

1.  Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic.

Authors:  Julian Harris; Mara Pillinger; Deborah Fromstein; Bayardo Gomez; Ivelisse Garris; Peter A Kanetsky; Pablo Tebas; Robert Gross
Journal:  AIDS Behav       Date:  2011-10

2.  Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy.

Authors:  Joseph A Simonetti; Matthew R Gingo; Lawrence Kingsley; Cathy Kessinger; Lorrie Lucht; Gk Balasubramani; Joseph K Leader; Laurence Huang; Ruth M Greenblatt; John Dermand; Eric C Kleerup; Alison Morris
Journal:  J AIDS Clin Res       Date:  2014-11

3.  A Mixed Methods Study of Anticipated and Experienced Stigma in Health Care Settings Among Women Living with HIV in the United States.

Authors:  Whitney S Rice; Bulent Turan; Faith E Fletcher; Tessa M Nápoles; Melonie Walcott; Abigail Batchelder; Mirjam-Colette Kempf; Deborah J Konkle-Parker; Tracey E Wilson; Phyllis C Tien; Gina M Wingood; Torsten B Neilands; Mallory O Johnson; Sheri D Weiser; Janet M Turan
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

4.  Coping styles and illicit drug use in older adults with HIV/AIDS.

Authors:  Linda M Skalski; Kathleen J Sikkema; Timothy G Heckman; Christina S Meade
Journal:  Psychol Addict Behav       Date:  2013-02-25

5.  Differential effects of perceived stress on alcohol consumption in moderate versus heavy drinking HIV-infected women.

Authors:  Heidi Hutton; Catherine R Lesko; Geetanjali Chander; Bryan Lau; Gary S Wand; Mary E McCaul
Journal:  Drug Alcohol Depend       Date:  2017-06-23       Impact factor: 4.492

6.  Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013.

Authors:  Chukwuemeka N Okafor; Robert L Cook; Xinguang Chen; Pamela J Surkan; James T Becker; Steve Shoptaw; Eileen Martin; Michael W Plankey
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-03       Impact factor: 3.829

7.  Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Milton Wainberg; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2013-11-05       Impact factor: 4.492

Review 8.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

9.  Relationship between trauma and high-risk behavior among HIV-positive men who do not have sex with men (MDSM).

Authors:  Kathryn Whetten; Susan Reif; Matthew Toth; Erica Jain; Jane Leserman; Brian W Pence
Journal:  AIDS Care       Date:  2012-08-22

10.  Reasons for drinking as predictors of alcohol involvement one year later among HIV-infected individuals with and without hepatitis C.

Authors:  Jennifer C Elliott; Malka Stohl; Efrat Aharonovich; Ann O'Leary; Deborah S Hasin
Journal:  Ann Med       Date:  2016-07-27       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.